Reuters logo
Britain's Alliance Pharma H1 revenue rises on strong sales abroad
September 13, 2017 / 6:31 AM / 11 days ago

Britain's Alliance Pharma H1 revenue rises on strong sales abroad

Sept 13 (Reuters) - British specialty pharmaceutical company Alliance Pharma Plc on Wednesday reported an 8.4 percent rise in first-half revenue, helped by international sales of its scar reduction product and eye supplement.

The company, listed on London’s junior stock market, said revenue rose to 50.3 million pounds ($66.9 million) for the six months ended June 30, from 46.4 million pounds a year ago.

Underlying profit before tax rose 1.7 percent to 11.9 million pounds during the period.

$1 = 0.7517 pounds Reporting By Justin George Varghese in Bengaluru; Editing by Amrutha Gayathri

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below